• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

口服补钙对未经治疗的高血压患者血压的影响:一项随机、双盲、安慰剂对照的交叉研究。

Effect of oral calcium supplementation on blood pressure in patients with previously untreated hypertension: a randomised, double-blind, placebo-controlled, crossover study.

作者信息

Galløe A M, Graudal N, Møller J, Bro H, Jørgensen M, Christensen H R

机构信息

Department of Internal Medicine P/chest clinic, Bispebjerg Hospital, Copenhagen, Denmark.

出版信息

J Hum Hypertens. 1993 Feb;7(1):43-5.

PMID:8450520
Abstract

It has been claimed that calcium lowers BP. The present randomised, double-blind, placebo-controlled crossover study is the first to investigate the effect on BP of a high oral dose of calcium given for a long period to patients with previously untreated hypertension. Elemental calcium (2 g) was administered for 12 weeks interchanging with a period of 12 weeks of placebo. Twenty patients completed the protocol. There was no significant difference in change of BP during the period of additional calcium intake when compared with placebo (P = 0.33). The risk of not detecting a real BP-lowering effect of calcium of at least 3 mmHg was < 5%. No evidence for the existence of a subgroup of 'responders' was found. It is concluded that a high daily dose of calcium supplementation given for 12 weeks does not decrease BP in previously untreated patients with mild to moderate hypertension.

摘要

据称钙可降低血压。本随机、双盲、安慰剂对照交叉研究首次调查了长期给予高口服剂量钙对未经治疗的高血压患者血压的影响。给予元素钙(2克)12周,期间穿插12周的安慰剂期。20名患者完成了该方案。与安慰剂相比,额外补钙期间血压变化无显著差异(P = 0.33)。未检测到钙至少降低3 mmHg血压的真实效果的风险<5%。未发现存在“反应者”亚组的证据。结论是,在12周内每日给予高剂量钙补充剂对未经治疗的轻至中度高血压患者的血压没有降低作用。

相似文献

1
Effect of oral calcium supplementation on blood pressure in patients with previously untreated hypertension: a randomised, double-blind, placebo-controlled, crossover study.口服补钙对未经治疗的高血压患者血压的影响:一项随机、双盲、安慰剂对照的交叉研究。
J Hum Hypertens. 1993 Feb;7(1):43-5.
2
A randomised, placebo-controlled, double-blind, crossover study of losartan and enalapril in patients with essential hypertension.氯沙坦与依那普利治疗原发性高血压的随机、安慰剂对照、双盲、交叉研究。
J Hum Hypertens. 2001 Mar;15(3):161-7. doi: 10.1038/sj.jhh.1001159.
3
[Effect of an oral calcium supplement in the treatment of slight-to- moderate essential arterial hypertension].口服钙剂治疗轻至中度原发性高血压的疗效
An Med Interna. 1989 Apr;6(4):192-6.
4
Double-blind crossover study of once daily nifedipine coat core in essential hypertension.硝苯地平缓释片每日一次治疗原发性高血压的双盲交叉研究。
J Hum Hypertens. 1994 Apr;8(4):289-92.
5
Effect of oral L-arginine supplementation on blood pressure: a meta-analysis of randomized, double-blind, placebo-controlled trials.口服 L-精氨酸补充对血压的影响:随机、双盲、安慰剂对照试验的荟萃分析。
Am Heart J. 2011 Dec;162(6):959-65. doi: 10.1016/j.ahj.2011.09.012. Epub 2011 Nov 8.
6
Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.一项三期、为期8周、多中心、前瞻性、随机、双盲、平行组临床试验的结果,该试验旨在评估坎地沙坦酯与苯磺酸氨氯地平对韩国轻至中度高血压成年人的疗效。
Clin Ther. 2007 Sep;29(9):1924-36. doi: 10.1016/j.clinthera.2007.09.018.
7
A 16-week, randomized, double-blind, placebo-controlled, crossover trial to quantify the combined effect of an angiotensin-converting enzyme inhibitor and a beta-blocker on blood pressure reduction.一项为期16周的随机、双盲、安慰剂对照、交叉试验,以量化血管紧张素转换酶抑制剂和β受体阻滞剂联合使用对降低血压的综合效果。
Clin Ther. 2008 Nov;30(11):2030-9. doi: 10.1016/j.clinthera.2008.11.003.
8
Evaluation by 24-hour ambulatory blood pressure monitoring of efficacy of manidipine hydrochloride 10, 20 or 40 mg once daily as compared to placebo in treating mild to moderate essential hypertension: a double-blind, randomized, parallel group, placebo-controlled study.通过24小时动态血压监测评估每日一次口服10毫克、20毫克或40毫克盐酸马尼地平与安慰剂相比治疗轻至中度原发性高血压的疗效:一项双盲、随机、平行组、安慰剂对照研究。
Blood Press Suppl. 1996;5:16-23.
9
Sibutramine is safe and effective for weight loss in obese patients whose hypertension is well controlled with angiotensin-converting enzyme inhibitors.对于高血压通过血管紧张素转换酶抑制剂得到良好控制的肥胖患者,西布曲明在减肥方面安全且有效。
J Hum Hypertens. 2002 Jan;16(1):5-11. doi: 10.1038/sj.jhh.1001298.
10
Efficacy and safety of sibutramine for weight loss in obese patients with hypertension well controlled by beta-adrenergic blocking agents: a placebo-controlled, double-blind, randomised trial.西布曲明用于β-肾上腺素能阻滞剂良好控制血压的肥胖高血压患者减肥的疗效和安全性:一项安慰剂对照、双盲、随机试验
J Hum Hypertens. 2002 Jan;16(1):13-9. doi: 10.1038/sj.jhh.1001299.

引用本文的文献

1
Calcium supplementation for the management of primary hypertension in adults.补充钙用于成人原发性高血压的管理。
Cochrane Database Syst Rev. 2006 Apr 19(2):CD004639. doi: 10.1002/14651858.CD004639.pub2.